Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours.

by Planting, A. S., van der Burg, M. E., de Boer-Dennert, M., Stoter, G., Verweij, J.
Published 1993

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.

by Henzen-Logmans, S. C., Berns, E. M., Klijn, J. G., van der Burg, M. E., Foekens, J. A.
Published 1992

A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.

by Verweij, J., Herweijer, H., Oosterom, R., van der Burg, M. E., Planting, A. S., Seynaeve, C., Stoter, G., Nooter, K.
Published 1991

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic colorectal cancer.

by Planting, A. S., van der Burg, M. E., van den Bent, M. J., de Boer-Dennert, M., Stoter, G., Verweij, J.
Published 1996

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.

by Schellens, J. H., Ma, J., Planting, A. S., van der Burg, M. E., van Meerten, E., de Boer-Dennert, M., Schmitz, P. I., Stoter, G., Verweij, J.
Published 1996

Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair.

by Ma, J., Verweij, J., Planting, A. S., de Boer-Dennert, M., van Ingen, H. E., van der Burg, M. E., Stoter, G., Schellens, J. H.
Published 1995